Featured patents

5-Fluorouracil-Resistant Bacteria and Method for Production Thereof
US 08734779 B2, May 27, 2014, Shun'ichiro Taniguchi et al. / Anaeropharma Science Inc. (Tokyo, JP)
A cytosine deaminase-expressing, 5-fluorouracil-resistant microorganism which can…

Streptococcus Suis Vaccines and Diagnostic Tests
US RE045170 E1, Sept. 30, 2014, Hilda Elizabeth Smith / Stichting Dienst Landbouwkundig Onderzoek (Wageningen, NL)
A composition, comprising:…

AAV Vectors for in Vivo Gene Therapy of Rheumatoid Arthritis
US 08529885 B2, Sept. 10, 2013, Christian Jorgensen et al. / Academisch Medisch Centrum (Amsterdam, NL)
A method for increasing expression of a therapeutic protein in a joint…

Apparatus and Method for Pre-conditioning/Fixation and Treatment of Disease With Heat Activation/Release With Thermoactivated Drugs and Gene Products
US 08765116 B2, July 1, 2014, John Mon / Medifocus, Inc. (Columbia, US)
An apparatus for administering a focused treatment into a targeted tissue region…

Artificial and Mutated Nucleotide Sequences
US 08747835 B1, June 10, 2014, Alexander Krichevsky / BioGlow, LLC (Saint Louis, US)
A nucleic acid construct, comprising the nucleotide sequences shown in SEQ ID…

Bifidobacterial Species
US 08658153 B2, Feb. 25, 2014, Françoise Gavini et al. / Universite de Liege (Angleur, BE)
An isolated Bifidobacterium GC61 comprising SEQ ID NO: 1, SEQ ID NO: 2,…

Breast Cancer Therapy Using an Engineered Respiratory Syncytial Virus
US 08597637 B1, Dec. 3, 2013, Weidong Zhang et al.
A method to treat breast cancer in a patient in need thereof, comprising:…

Canine Probiotic Bifidobacteria Globosum
US 08840880 B2, Sept. 23, 2014, Gary Mitchell Davenport et al. / The Iams Company (Cincinnati, US)
A method of maintaining or improving the health of a companion animal comprising…

Cell Capable of Expressing Exogenous GITR Ligand
US 08586023 B2, Nov. 19, 2013, Junichi Mineno et al. / Mie University (Mie, JP)
A pharmaceutical composition comprising an excipient and an immune cell capable…

Commensal Bacteria as Signal Mediators Within a Mammalian Host
US 08771668 B2, July 8, 2014, Franklin Faping Duan et al. / Cornell University (Ithaca, US)
A method treating diabetes in a mammalian host comprising:…

Compositions and Methods for Treating Hypophosphatasia
US 08691208 B2, April 8, 2014, Seiji Yamaguchi et al. / Saint Louis University (St. Louis, US)
A method for treating hypophosphatasia in a patient comprising administering…

Compositions Comprising Angiogenic Factors and Methods of Use Thereof
US 08778329 B2, July 15, 2014, Paulo Maciag et al. / The Trustees of the University of Pennsylvania (Philadelphia, US)
A method of inducing an immune response against a tumor vasculature of a tumor…

Cosmid DNA Constructs and Methods of Making and Using Same
US 08529884 B2, Sept. 10, 2013, Jeong-Im Sin et al. / The Trustees of the University of Pennsylvania (Philadelphia, US)
A method of inducing a humoral and cellular immune response in an individual…

Directed Evolution and in Vivo Panning of Virus Vectors
US 08632764 B2, Jan. 21, 2014, Lin Yang et al. / University of North Carolina at Chapel Hill (Chapel Hill, US)
A nucleic acid encoding an AAV capsid, the nucleic acid comprising an AAV capsid…

Duplexed Parvovirus Vectors
US 08784799 B2, July 22, 2014, Douglas M. McCarty et al. / The University of North Carolina at Chapel Hill (Chapel Hill, US)
An adeno-associated virus (AAV) particle comprising:…

G-Substrate for the Treatment and Prevention of Parkinson's Disease
US 08545834 B2, Oct. 1, 2013, Chee-Yeun Chung et al. / The McLean Hospital Corporation (Belmont, US)
A method for treating Parkinson's Disease in a patient, said method comprising…

Gene Delivery System and Method of Use
US 08652460 B2, Feb. 18, 2014, W. French Anderson et al. / University of Southern California (Los Angeles, US)
A replication competent mammalian oncoretrovirus comprising:…

Gene Delivery System and Methods of Use
US 08741279 B2, June 3, 2014, W. French Anderson et al. / University of Southern California (Los Angeles, US)
A method of treating a mammalian subject having a cell proliferative disorder…

Gene Expression Cassette and a Transformant, and a Method for Manufacturing 2-Deoxy-Scyllo-Inosose and a Method for Purifying 2-Deoxy-Scyllo-Inosose Using Said Transformant
US 08758741 B2, June 24, 2014, Katsumi Ajisaka et al. / Mitsui Chemicals, Inc. (Tokyo, JP)
An isolated host cell comprising a gene expression cassette having a gene…

Genetically Modified Bacterium of the Species Listeria Monocytogenes
US 08808683 B2, Aug. 19, 2014, Martin Wagner et al. / Merck Patent GmbH (Darmstadt, DE)
A genetically modified bacterium of the species Listeria monocytogenes…

Identification of Protective Antigenic Determinants of Porcine Reproductive and Respiratory Syndrome Virus and Uses Thereof
US 08771670 B2, July 8, 2014, Delbert Linn Harris et al. / Iowa State University Research Foundation, Inc. (Ames, US)
A method for treating a porcine reproductive respiratory syndrome virus—(PRRSV)…

Immunization And/Or Treatment of Parasites and Infectious Agents by Live Bacteria
US 08771669 B1, July 8, 2014, David Gordon Bermudes
A genetically engineered bacterium being attenuated and pharmaceutically…

Immunostimulatory Nucleic Acid Packaged Particles for the Treatment of Hypersensitivity
US 08574564 B2, Nov. 5, 2013, Conrad Johannes Coester et al. / Cytos Biotechnology AG (Zurich-Schlieren, CH)
A method of treating a hypersensitivity in an animal, wherein said…

Influenza Composition
US 08668904 B2, March 11, 2014, Emmanuel Jules Hanon / Glaxosmithkline Biologicals S.A. (Rixensart, BE)
A method of inducing a primary immune response against influenza virus in a human…

Light Emitting Microorganisms and Cells for Diagnosis and Therapy of Tumors
US 08586022 B2, Nov. 19, 2013, Tatyana Timiryasova et al. / Genelux Corporation (San Diego, US)
A method of tumor therapy, comprising:…

Light Emitting Microorganisms and Cells for Diagnosis and Therapy of Tumors
US 08568707 B2, Oct. 29, 2013, Tatyana Timiryasova et al. / Genelux Corporation (San Diego, US)
A method for treating a tumor, tumor tissue, cancer or metastasis, comprising:…

Live, Oral Vaccine for Protection Against Shigella Dysenteriae Serotype 1
US 08790635 B2, July 29, 2014, Dennis J. Kopecko et al. / The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, US)
A vaccine comprising:…

Long Lasting Drug Formulations
US 08586024 B2, Nov. 19, 2013, Andrew L. Pearlman et al. / Medgenics Medical Israel Ltd. (Misgav, IL)
A long-lasting therapeutic formulation for implanting into an immunocompetent…

Long Lasting Drug Formulations
US 08454948 B2, June 4, 2013, Andrew L. Pearlman et al. / Medgenics Medical Israel Ltd. (Misgav, IL)
A long-lasting erythropoietin formulation comprising at least one genetically…

Method of Preventing Early Lawsonia Intracellularis Infections
US 08734781 B2, May 27, 2014, Knut Elbers et al. / Boehringer Ingelheim Vetmedica, Inc. (St. Joseph, US)
A method of reducing early Lawsonia intracellularis infection in piglets…

Patentorg has 62 documents under Genetically Modified Micro-Organism, Cell, or Virus Patents.

Other subcategories for category Drug, bio-affecting and body treating compositions
Quick navigation
New documents
  • Process for the Production of the Actinobacillus Pleuropneumoniae Toxins APXI or APXIII in a Liquid Culture Medium Under Supply of Air Enriched in Carbon Dioxide
  • Method for Manufacturing Nonvolatile Memory Device
  • Supply Chain Demand Satisfaction
  • Supply-Line Management Device
  • Storage Control Device and Method for Managing Snapshot